Evaluation of patupilone as monotherapy in patients with advanced hepatocellular carcinoma (HCC)

被引：0
|
作者：
Venook, A. P.
Poon, R.
Kang, Y. K.
Mok, T. S.
Chao, Y.
de Bedout, S.
Harbott, A.
Li, J.
Johri, A. R.
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China
[3] Asan Med Ctr, Seoul, South Korea
[4] Chinese Univ Hong Kong, Hong Kong, Peoples R China
[5] Vet Gen Hosp, Taipei, Taiwan
[6] Novartis Pharmaceut, E Hanover, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15055
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC)
    Pazo-Cid, R. A.
    Lanzuela, M.
    Esquerdo, G.
    Perez-Gracia, J. L.
    Anton, A.
    Amigo, G.
    Martinez Trufero, J.
    Garcia-Otin, A. L.
    Martin-Duque, P.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (08): : 564 - 574
  • [42] Risk-stratified management of advanced hepatocellular carcinoma (HCC)
    Pinato, D. J.
    Kaplan, D. E.
    Yen, C.
    Rimassa, L.
    Dominik, B.
    Pressiani, T.
    Thimme, R.
    Pirisi, M.
    Burlone, M.
    Arizumi, T.
    Kudo, M.
    Park, J. W.
    Taddei, T. H.
    Johnson, P.
    Sharma, R.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S196 - S196
  • [43] Intraarterial chemotherapy with cisplatin and etoposide for advanced hepatocellular carcinoma (HCC).
    Sangro, B
    Rios, R
    Herrero, I
    Quiroga, J
    Bilbao, I
    Beloqui, O
    Prieto, J
    HEPATOLOGY, 1999, 30 (04) : 677A - 677A
  • [44] Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC)
    R. A. Pazo-Cid
    M. Lanzuela
    G. Esquerdo
    J. L. Pérez-Gracia
    A. Antón
    G. Amigo
    J. Martínez Trufero
    A. L. García-Otín
    P. Martín-Duque
    Clinical and Translational Oncology, 2012, 14 : 564 - 574
  • [45] Sorafenib in advanced hepatocellular carcinoma (HCC) : Ascites as prognostic factor
    Koch, S.
    Niederle, I.
    Gamstaetter, T.
    Schuchmann, M.
    Galle, P.
    Woerns, M.
    Weinmann, A.
    INTERNIST, 2013, 54 : 10 - 10
  • [46] A phase I study of ganetespib in advanced hepatocellular carcinoma (HCC)
    Goyal, Lipika
    Wadlow, Raymond Couric
    Blaszkowsky, Lawrence Scott
    Wolpin, Brian M.
    Vasudev, Eamala
    Sheehan, Susan
    Knowles, Michelle
    Zhu, Andrew X.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [47] The hepatocellular carcinoma (HCC)
    Zendeh, D
    Holle, A
    Liebe, S
    MEDIZINISCHE WELT, 1998, 49 (10): : 489 - 498
  • [48] HEPATOCELLULAR CARCINOMA (HCC)
    Villanueva, A.
    ANNALS OF ONCOLOGY, 2014, 25
  • [49] M2b monocytes predominantly appear in patients with advanced hepatocellular carcinoma (HCC patients)
    Asai, Akira
    Tsuchimoto, Yusuke
    Fukunishi, Shinya
    Tsuda, Yasuhiro
    Fukuda, Akira
    Kobayashi, Makiko
    Suzuki, Fujio
    Higuchi, Kazuhide
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [50] Donafenib as a first-line monotherapy for advanced hepatocellular carcinoma
    Zhang, Bo -Han
    Cai, Yun-Shi
    Jiang, Li
    Yang, Jia-Yin
    HEPATOBILIARY SURGERY AND NUTRITION, 2021, 10 (05) : 737 - 740
12345